Can One Letter in DNA Rewrite a Human Life? | Dr. Murtadha Ali | TEDxBaghdad

Quick Overview

Dr. Murtadha Ali demonstrates how rapid whole-genome sequencing, costing around $1000 and taking less than 48 hours, successfully diagnosed two Iraqi families with previously unknown rare genetic disorders, leading to earlier intervention and potentially saving lives by identifying the causative mutations in the $LGI3$ and $DOCK8$ genes.

Key Points: Around 300 million people worldwide are affected by rare diseases, 80% of which are genetic in origin, often manifesting in children (50% of the patient population). The average time-to-diagnosis for these rare genetic diseases is 5-8 years, highlighting a significant diagnostic odyssey. Dr. Ali's research focused on two specific families from Iraq and Pakistan, both suffering from unknown conditions involving global developmental delays, skeletal defects, and immune deficiencies. Utilizing Next Generation Sequencing (NGS) on the Iraqi family's genome, researchers identified a novel bi-allelic $LGI3$ variant causing intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects. The Pakistani family, after 10 years and over $70K in testing, was diagnosed with a $DOCK8$ variant, responsible for immune deficiency and severe skin issues, through whole-genome sequencing. These advanced sequencing techniques drastically reduce the diagnostic timeline from years to under 48 hours, costing around $1000 per genome. The ultimate goal of the Iraqi Genome Project is to translate this rapid diagnosis into early intervention and potential gene therapy, saving lives that might otherwise be lost.

Context: Dr. Murtadha Ali presents at TEDxBaghdad on the challenges and triumphs associated with diagnosing rare genetic diseases, particularly focusing on the journey families endure when facing an unknown diagnosis. He contrasts the historical difficulty and expense of genetic identification—citing the original human genome sequencing costing 15 years and $3 billion—with modern, rapid whole-genome sequencing techniques that provide answers in days for a fraction of the cost, offering hope for affected families in Iraq and beyond.